 Connection
Luisa Mestroni to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Luisa Mestroni has written about Adrenergic beta-Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.132 |
|
|
|
-
Taylor MR, Slavov D, Humphrey K, Zhao L, Cockroft J, Zhu X, Lavori P, Bristow MR, Mestroni L, Lazzeroni LC. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure. Pharmacogenet Genomics. 2009 Jan; 19(1):35-43.
Score: 0.072
-
Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. J Am Coll Cardiol. 1999 Jun; 33(7):1926-34.
Score: 0.037
-
Sinagra G, Perkan A, Di Lenarda A, Lardieri G, Pinamonti B, Mestroni L, Miani D, Camerini F. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients]. G Ital Cardiol. 1992 Aug; 22(8):969-89.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|